Detection of circulating natural antibodies to inflammatory cytokines in type-2 diabetes and clinical significance

Abstract

BackgroundInflammatory cytokines have been demonstrated to be involved in developing insulin resistance and type-2 diabetes (T2D). Natural antibodies in the circulation have protective effects on common diseases in humans. The present study was thus designed to test the hypothesis that natural antibodies against inflammatory cytokines could be associated with T2D.MethodsAn enzyme-linked immunosorbent assay (ELISA) was developed in-house to detect plasma IgG against peptide antigens derived from interleukin 1α (IL1α), IL1β, IL6, IL8 and tumor necrosis factor-α (TNF-α) in 200 patients with T2D and 220 control subjects.ResultsBinary regression showed that compared with control subjects, T2D patients had a decreased level of plasma anti-IL6 IgG (adjusted r 2=0.034, p=0.0001), anti-IL8 IgG (adjusted r 2=0.021, p=0.002) and anti-TNF-α IgG (adjusted r 2=0.017, p=0.003). Female patients mainly contributed to decreased levels of anti-IL6 IgG (adjusted r 2=0.065, p=0.0008) and anti-IL8 IgG (adjusted r 2=0.056, p=0.003), while male patients mainly contributed to decreased anti-TNF-α IgG levels (adjusted r 2=0.024, p=0.005). ROC curve analysis revealed a sensitivity of 16.5% against specificity of 95.5% for anti-IL6 IgG assay and a sensitivity of 19.5% against specificity of 95.9% for anti-IL8 IgG assay. Glycated hemoglobin levels measured after 6-month glucose-lowering treatment appeared to be inversely correlated with plasma anti-IL1α IgG (r=-0.477, df=17, p=0.039) and anti-IL6 IgG (r=-0.519, df=17, p=0.023) although such correlation failed to survive the Bonferroni correction.ConclusionsDeficiency of natural IgG against inflammatory cytokines is likely to be a risk factor for T2D development and detection of such antibodies may be useful for personalized treatment of the disease.Electronic supplementary materialThe online version of this article (10.1186/s12950-017-0171-6) contains supplementary material, which is available to authorized users.

Identification of differentially expressed genes in the endothelial precursor cells of patients with type 2 diabetes mellitus by bioinformatics analysis

“…However, a wide variety of nucleated cells, including EPCs, are potential sources of IL8 (46). Previous studies have indicated that in patients with type 2 DM, IL8 is elevated in the plasma compared with that in healthy subjects (47). IL8 is considered a canonical angiogenic factor and has a crucial role in the protection of EPCs for attenuating injury and prompting recovery of damaged tissues (48–50).…”

Role of 2‑series prostaglandins in the pathogenesis of type 2 diabetes mellitus and non‑alcoholic fatty liver disease (Review)

“…Under hyperglycemic states, crosstalk between PGs and other inflammatory factors has a profound effect on glycemic control. Systemic inflammatory responses are upregulated in T2dM individuals (122), characterized by elevated levels of lipid molecules, including PGs and cytokines such as TNF-α (123), IL-1β (124), IL-6 (125) and IL-8 (126), in correspondence with the decline of their natural antibodies (127). In PG signaling, cOX-2 is involved in IL-1β-induced auto-stimulation in islets (111).…”

Mineralocorticoid receptor in cardiovascular diseases -- clinical trials and mechanistic insights

“…The MR is involved in the activation of numerous signaling pathways in vascular smooth muscle cells (VSM-Cs) including extracellular signal-regulated kinase (ERK), mitogen-activated protein kinase (MAPK), the tyrosine kinase c-Src, c-jun N terminal kinase (JNK), epidermal growth factor receptor (EGFR) or myosin phosphate target subunit-1 (MYPY1), leading to VSMC stress fiber formation, migration, inflammation and oxidative stress (Mazak et al, 2004;Callera et al, 2005aCallera et al, , 2005bMiyata et al, 2008;Cai et al, 2017). Of special interest, aldosterone mediated by MR activation increased the expression of Gal-3 in a dose-and time-dependent manner in VSMCs (Calvier et al, 2013).…”